DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumar, S.
Right arrow Articles by Rurak, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar, S.
Right arrow Articles by Rurak, D. W.

Vol. 28, Issue 3, 279-285, March 2000

Diphenhydramine Disposition in the Sheep Maternal-Placental-Fetal Unit: Gestational Age, Plasma Drug Protein Binding, and Umbilical Blood Flow Effects on Clearance

Sanjeev Kumar, George R. Tonn, K. Wayne Riggs, and Dan W. Rurak

Division of Pharmaceutics and Biopharmaceutics, Faculty of Pharmaceutical Sciences (S.K., G.R.T., and K.W.R.) and B.C. Research Institute of Children's and Women's Health, Department of Obstetrics and Gynecology, Faculty of Medicine (D.W.R.), The University of British Columbia, Vancouver, British Columbia, Canada

The objective of this study was to examine the interrelationships between maternal and fetal plasma drug protein binding, umbilical blood flow (Qum), gestational age (GA), and maternal-fetal diphenhydramine (DPHM) clearances in chronically instrumented pregnant sheep. Maternal and fetal DPHM placental (CLmf and CLfm, respectively) and nonplacental (CLmo and CLfo, respectively) clearances and steady-state plasma protein binding were determined in 18 pregnant sheep at 124 to 140 days' gestation (term, ~145 days). The data demonstrated a highly significant fall of ~66% in CLfm and a decreasing trend in CLfo (~47%) over the GA range studied. However, no such relationships existed between GA and CLmf or CLmo. Concomitant with this was a decrease in fetal DPHM plasma unbound fraction with GA, with no such change being evident in the mother. Both CLmo and CLfo were related to the respective DPHM plasma unbound fraction. A strong relationship also existed between fetal plasma unbound fraction and CLfm. Thus, the decrease in fetal unbound fraction of DPHM during gestation could contribute to the fall in CLfm, and possibly CLfo. However, over the GA range studied, fetal DPHM free fraction decreased by ~47%, whereas CLfm fell by ~66%. Because fetal unbound fraction and CLfm are linearly related, the GA-associated fall in unbound fraction appears to be insufficient to account for the entire decline in CLfm. In separate studies in pregnant sheep, we observed a ~40% fall in weight-normalized Qum between 125 and 137 days' gestation. Because CLfm for DPHM is similar to that of flow-limited compounds (e.g., ethanol, antipyrine), this decrease in Qum may also contribute to the GA-related fall in CLfm.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
S. C.S. Au-Yeung, K. W. Riggs, N. Gruber, and D. W. Rurak
The Use of Microdialysis for the Study of Drug Kinetics: Central Nervous System Pharmacokinetics of Diphenhydramine in Fetal, Newborn, and Adult Sheep
Drug Metab. Dispos., August 1, 2007; 35(8): 1285 - 1291.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Kumar, H. Wong, S. A. Yeung, K. W. Riggs, F. S. Abbott, and D. W. Rurak
Disposition of Valproic Acid in Maternal, Fetal, and Newborn Sheep I: Placental Transfer, Plasma Protein Binding, and Clearance
Drug Metab. Dispos., July 1, 2000; 28(7): 845 - 856.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.